Peter F. Searle - Concepedia

Author

Peter F. Searle

Also Known As

P F Searle, P Searle, P. F. Searle, P. Searle, P.F Searle, P.F. Searle, PETER F. SEARLE, Peter F Searle, Peter F. Searle, Peter Searle

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Cancer Research UK Cancer Research UK Clinical Trials Unit University of Washington Howard Hughes Medical Institute

About

Peter F. Searle is an author at University of Birmingham specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	2.3K
2	Natural Sciences	9	9	1.3K
3	Engineering	3	3	323
4	Health Sciences	1	1	15
5	Public Health	1	1	19

Peter F. Searle

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
A 12-base-pair DNA motif that is repeated several times in metallothionein gene promoters confers metal regulation to a heterologous gene. Gary W. Stuart, Peter F. Searle, H Y Chen, Proceedings of the National Academy of Sciences Molecular RegulationGeneticsMolecular BiologyMolecular GeneticsDna Sequences	1984	405
Identification of multiple metal regulatory elements in mouse metallothionein-I promoter by assaying synthetic sequences Gary W. Stuart, Peter F. Searle, Richard D. Palmiter Nature Synthetic SequencesSystems BiologyBiochemistryNatural SciencesGenetics	1985	358
Regulation, linkage, and sequence of mouse metallothionein I and II genes. Peter F. Searle, Barry L. Davison, Gary W. Stuart, Molecular and Cellular Biology GeneticsGenomic MechanismMolecular GeneticsTranscriptional RegulationIi Genes	1984	335
Structural and Mechanistic Studies of Escherichia coli Nitroreductase with the Antibiotic Nitrofurazone Paul R. Race, Andrew L. Lovering, Richard M. Green, Journal of Biological Chemistry	2005	213
Building a metal-responsive promoter with synthetic regulatory elements. Peter F. Searle, Gary W. Stuart, R D Palmiter Molecular and Cellular Biology EngineeringGeneticsMolecular BiologySynthetic Regulatory ElementsEpigenetics	1985	197
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector. James P. F. Latham, Peter F. Searle, Vivien Mautner, PubMed Transcriptional RegulationProstate-specific Antigen Promoter/enhancerSignal TransductionProtein ExpressionCmv Promoter	2000	164
Vectors based on reducible polycations facilitate intracellular release of nucleic acids Martin L. Read, K. Helen Bremner, David Oupický, The Journal of Gene Medicine	2003	148
Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954. G Chung-Faye, Daniel H. Palmer, David A. Anderson, PubMed Pharmacokinetic StudyPathologyPharmacotherapyAntiviral DrugDrug Resistance	2001	137
Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer Daniel H. Palmer, Vivien Mautner, Darius F. Mirza, Journal of Clinical Oncology	2004	129
A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984 Prashant Patel, Joanna Young, Vivien Mautner, Molecular Therapy	2009	124

Page 1